Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells

Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer

(2019) Gillianne G.Y. Lai et al.   JOURNAL OF CLINICAL ONCOLOGY

Metformin promotes survivin degradation through AMPK/PKA/GSK-3β-axis in non-small cell lung cancer

(2019) Zhuang Luo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

(2019) Paola Bordi et al.   LUNG CANCER

Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis

(2019) Di Lu et al.   Cancer Management and Research

Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy

(2019) Tianyi Ye et al.   Cancer Biomarkers

Systematic review and network meta-analysis of first-line therapy for advanced EGFR-positive non-small-cell lung cancer

(2019) Jacob Franek et al.   Future Oncology

Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer

(2019) Yücel Başpınar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Natural products in licorice for the therapy of liver diseases: Progress and future opportunities

(2019) Xiaojiaoyang Li et al.   PHARMACOLOGICAL RESEARCH

Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma

(2019) Yuli Hao et al.   OncoTargets and Therapy

MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin

(2019) Minmin Yu et al.   Cancer Management and Research

Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma

(2019) Li Zhang et al.   Annals of Translational Medicine

Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer

(2019) TOMOMI SANOMACHI et al.   ANTICANCER RESEARCH

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

(2019) Alessandro Leonetti et al.   BRITISH JOURNAL OF CANCER

Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updates

(2019) Nicolas Girard   Future Oncology

Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?

(2019) Fengzhi Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study

(2019) Samaneh Reiszadeh-Jahromi et al.   NEUROCHEMICAL RESEARCH

Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?

(2019) Sanjal Desai et al.   Current Oncology Reports

The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models

(2019) David Martínez-García et al.   Biomolecules

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

(2019) Camille Mehlman et al.   LUNG CANCER

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

(2019) Ana C.Z. Gelatti et al.   LUNG CANCER

Acquired resistance in oncogene-addicted non-small-cell lung cancer

(2018) Claudio Sini et al.   Future Oncology

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

(2018) Jean-Charles Soria et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis

(2018) Xianghe Liu et al.   OncoTargets and Therapy

Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells

(2018) Wei Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Biological Effects Of Licochalcones

(2018) Daniela Maria Pia Gatta et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?

(2018) Gonzalo Recondo et al.   Nature Reviews Clinical Oncology

Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin

(2018) PREEYAPORN PLAIMEE PHIBOONCHAIYANAN et al.   ANTICANCER RESEARCH

Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway

(2017) Wei Li et al.   Cancer Medicine

Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis

(2016) Liang Duan et al.   BMC CANCER

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

(2015) Pasi A. Jänne et al.   NEW ENGLAND JOURNAL OF MEDICINE

3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer

(2014) Yuqiao Sheng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

(2014) D. A. E. Cross et al.   Cancer Discovery

Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways

(2012) Chung Soo Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma

(2012) Chunguang Li et al.   PLoS One

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

(2009) Uta B. Hofmann et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Licorice and Licochalcone-A Induce Autophagy in LNCaP Prostate Cancer Cells by Suppression of Bcl-2 Expression and the mTOR Pathway

(2009) Yi-Te Yo et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY